We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Pioneering COVID-19 Testing Platform Combines Saliva-Based Sampling, Pooled Testing and PCR Diagnostics

By LabMedica International staff writers
Posted on 09 Mar 2021
A pioneering COVID-19 testing platform combines saliva-based sampling, pooled testing and PCR diagnostics to enable high-quality, high-throughput, low-cost detection of SARS-CoV-2.

Mirimus, Inc.’s (Brooklyn, NY, USA) SalivaClear platform is designed to provide a SARS-CoV-2 diagnostic system that can be easily and repeatedly utilized by myriad organizations, from schools to businesses to government organizations, to test (and retest) groups of individuals in order to quickly isolate COVID-19 hotspots before they can become outbreaks. More...
Mirimus has innovated high-volume COVID-19 PCR testing with SalivaClear, a three-stage surveillance and individual reflex testing strategy to monitor and detect infection in populations by testing people in groups called pools. All three-stages of testing are performed with only one self-collected saliva sample.

For collecting the sample, Mirimus uses a simple self-collection method that is composed of a 2 mL cryogenics vial and saliva collection aid (straw). The saliva straw fits into a cryogenic vial and the testing individual deposits 1 mL of saliva through the straw into the vial. 1 mL of saliva is required for pool testing, subpool testing, and individual diagnostic testing. The individual samples are then shipped to Mirimus' lab where they are pooled into groups of 24 and analyzed using the FDA Emergency Use Authorized ThermoFisherScientific TaqPathCOVID-19 Combo RT-PCR Kit. The pooled test results are typically reported within 24 hours of sample receipt at the laboratory. If a pool tests positive, it is split into 12 pools of two, which are re-tested at the laboratory. If a positive signal emerges from a two-sample pool, the two individuals are asked to provide consent for a final test to determine individual positivity. SalivaClear has been shown to substantially reduce the cost associated with PCR testing and allow schools to rapidly assess transmission and make data-driven decisions to adjust prevention protocols.

"Colleges and universities have, unfortunately, been associated with a substantial number of COVID-19 cases across the country, with a recent report from The New York Times suggesting that more than 120,000 COVID-19 cases have been linked to American colleges and universities since January 1st," said Prem Premsrirut, M.D., Ph.D., Co-founder and CEO of Mirimus. "Given this, the robust surveillance testing that SalivaClear provides is essential to ensuring a safe on-campus learning environment by enabling campus health administrators to quickly isolate hotspots before they can become outbreaks."

Related Links:
Mirimus, Inc.


Platinum Member
Fully Automatic ACLIA Analyzer
MAGLUMI X8
Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
POC Immunoassay Analyzer
Procise DX
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The method combines ultrasonic and fluorescence techniques to track amyloid aggregation in real time (Image Credit: Shutterstock)

Blood Test Measures Amyloid Seeding Activity to Detect Alzheimer’s Disease

Early, accurate diagnosis of Alzheimer’s disease (AD) remains challenging in routine practice, despite its role as the leading cause of dementia worldwide. Confirmation typically relies on cerebrospinal... Read more

Pathology

view channel
Image: TRUECAM automatically eliminates ambiguous or uninformative regions in whole-slide pathology images, enhancing the reliability of diagnostic analysis. (Photo courtesy of PolyU)

AI-Pathologist Framework Improves Accuracy and Reliability in Cancer Diagnosis

Ensuring reliable cancer diagnosis from digital pathology remains a critical challenge as clinical decisions rely on accurate slide interpretation. While artificial intelligence (AI) has accelerated whole-slide... Read more

Industry

view channel
Image: HealthTab will distribute the Abbott Afinion 2 Analyzer to NHS-linked pharmacies for hemoglobin A1c (HbA1c) and lipid profile testing. (Photo courtesy of Abbott)

New Collaboration Expands Point-of-Care Testing Across UK Community Pharmacies

HealthTab, a wholly owned subsidiary of Avricore Health, has entered a formal collaboration agreement with Abbott to supply and distribute Abbott’s point-of-care testing products in the UK through the... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.